Medical School:

• University of California at Los Angeles, Los Angeles, CA

Internship:

• University of Michigan Medical Center, Ann Arbor, Michigan

Residency:

• University of Michigan Medical Center, Ann Arbor, Michigan

Fellowship:

• Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada

Certification:

• American Board of Surgery, Diplomat

Societies, Organizations, and Honors:

• Phi Beta Kappa
• Alpha Omega Alpha
• American College of Surgeons Faculty Research Fellowship (2000-2002)
• Outstanding Teacher Award, Depart. of Surgery, Medical College of Wisconsin (2002)
• American Association of Clinical Endocrinologists 
• American Association of Endocrine Surgeons 
• American College of Surgeons Fellow
• American College of Surgeons Oncology Group 
• Association of Academic Surgeons
• Central Surgical Association
• International Association of Endocrine Surgeons
• Society of Surgical Oncology
• Society of University Surgeons
• The Coller Society
• The Endocrine Society Wisconsin
• Surgical Society

Selected Publications:

• Sugg SL, Fraker DL, Alexander R, Doppman JL, Miller DL, Chang R, Skarulis MC, Marx SJ, Spiegel AM, Norton JA. Prospective evaluation of selective venous sampling for parathyroid hormone concentration in patients undergoing reoperations for primary hyperthyroidism. Surgery (1993 Dec) 114(6):1004-9.
• Sugg SL, Norton JA, Fraker DL, Metz DC, Pisegna JR, Fishbeyn V, Benya RV, Shawker TH, Doppm,an JL, Jensen RT. Annals of Surgery (1993 Aug) 21) 218(2):138-44.
• Sugg SL, Gerndt SR, Hamilton BJ, Francis IR, Taheri PA, Rodriguez JL. Pseudoaneurysms of the intraparenchymal splenic artery following bunt abdominal trauma: A complication of nonoperative therapy and its management. Journal of Trauma (1995 Sep) 39(3):593-5.
• Sugg SL, Zheng L, Ezzat S, Rosen IB, Freeman JL, Asa SL. Ret/PTC-1,-2,-3 oncogene rearrangements in human thyroid carcinoma: implications for metastatic potential? Journal of Clinical Endocrinology and Metabolism (1996 Sep) 81:3360-5.
• Sugg SL. Zheng L. Ezzat S, Rosen IB, Freeman JL, Asa SL. Distinct multiple ret/PTC gene rearrangements in multifocal papillary thyroid neoplasia. Journal of Clinical Endocrinology and Metabolism, (1998 Nov) 83(11):4116-22.
• Sugg SL, Zheng L, Rosen IB, Freeman JL, Ezzat S. Asa SL. ErbB-2 Cytoplasmic staining but not mRNA levels correlate with differentiation in human thyroid neoplasm. Clinical Endocrinology, 1998;49:629-637.
• Sugg SL, Zheng, Freeman JL, Rosen IB, Ezzat S, Asa SL. Oncogene profile of papillary thyroid carcinoma. Surgery, 1999;125:46-52.
• Soravia C, Sugg SL, Berk T, Mitri A, Cheng H, Gallinger S, Cohen Z, Asa SL, Bapat BV. Familial adenomatous polyposis coli associated thyroid cancer: a clinical, pathological, and molecular genetic study. American Journal of Pathology, 1999;54:127-135.
• Sugg SL, Ferguson DJ, Posner MC, Heimann R. Should internal mammary nodes be sampled in the sentinel lymph node era? Annals of Surgical Oncology, 2000;7:188-192. Abstracted in Breast Diseases: A Year Book Quarterly, 2000.
• Witteles RM, Straus FH, Sugg SL, Koka MR, Costa EA, Kaplan EL. Adult nesidioblastosis causing hypoglycemia.  An uncommon but important clinical entity. Arch Surg. 2001 Jun;136(6):656-63. Review.
• Jaskowiak NT, Sugg SL, Helke J, Koka MR, Kaplan EL. Pitfalls of intraoperative quick parathyroid hormone monitoring and gamma probe localization in surgery for primary hyperparathyroidism. Arch Surg 2002 Jun;137(6):659-68
• Chen X, Doffek K, Sugg SL, Shilyansky J. Neuroblastoma cells inhibit the immunostimulatory function of dendritic cells.  J Pediatr Surg 2003 Jun;38(6):901-5.
• Gillanders WE, Mikhitarian K, Hebert R, Mauldin PD, Palesch Y, Walters C, Urist MM, Mann GB, Doherty G, Herrmann VM, Hill AD, Eremin O, El-Sheemy M, Orr RK, Valle AA, Henderson MA, Dewitty RL, Sugg SL, Frykberg E, Yeh K, Bell RM, Metcalf JS, Elliott BM, Brothers T, Robison J, Mitas M, Cole DJ. Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study. Ann Surg. 2004 Jun;239(6):828-37; discussion 837-40.
• Nicholl M, Lodge A, Brown I, Sugg SL, and Shilyansky J. Restored immune response to an MHC-II-Restricted antigen in tumor-bearing hosts after elimination of regulatory T cells. J Pediatr Surg. 2004. June;39(6): 941-6.
• Chen X, Doffek K, Sugg SL, and Shilyansky J. Phosphatidylserine Regulates the Maturation of Human Dendritic Cells.  J Immunology 2004 Sept 1; 173(5): 2985-2994.
• Sugg SL,  Krzywda EA, Demeure MJ, and Wilson SJ.  Detection of multiple gland primary hyperparathyroidism in the era of minimally invasive parathyroidectomy.  Surgery 2004 Dec; 136(6): 1303-9.
• Doffek K, Chen X, Gavin C, Sugg S, Shilyansky J.: PS modulates DC maturation and function by inhibiting ERK1/2, NFkB and p38 MAPK activation in response to LPS.  International Proceedings of Immunology, 2004. 395-400.
• Lodge A, Yu P, Nicholl M, Brown I, Jackson C, Schreiber K, Sugg S, Schreiber H, Shilyansky J. CD40 ligation restores cytolytic T lymphocyte (CTL) response and eliminates murine fibrosarcoma in mice lacking CD4+ T cells. Cancer Immunology Immunotherapy. 2006. Dec;55(12):1542-52.
• Yen TW, Wilson SD, Krzywda EA, Sugg SL. The role of parathyroid hormone (PTH) measurements after surgery for primary hyperparathyroidism. Surgery. 2006 Oct;140(4):665-72; discussion 672-4.
• Shilyansky J, Jacobs P, Doffek K, Sugg SL. Induction of cytolytic T lymphocytes (CTL) against pediatric solid tumors in vitro using autologous DCs pulsed with necrotic primary tumor. J Pediatr Surg. 2007 Jan;42(1):54-61.
• Sinkevicius KW, Burdette JE, Woloszyn  K, Hweitt SC, Hamilton K, Sugg  SL, Temple KA, Wondisford FE, Korach KS, Woodruff TK, and Greene GL. An estrogen receptor α knock-in mutation provides evidence of ligand-independent signaling and allows modulation of ligand-induced pathways in vivo. Endocrinology.  2008 Jun;149(6):2970-9.
• Adamovic T, McAllister D, Rowe JJ, Wang T, Jacob HJ, Sugg SL. Genetic mapping of mammary tumor traits to rat chromosome 10 using a novel panel of consomic rats. Cancer Genet Cytogenet. 2008 Oct; 186(1):41-8.
• Wilson SD, Krzywda EA, Zhu YR, Yen TWF, Wang TS, Sugg SL, Pappas SG. The influence of surgery in MEN-1 syndrome: observations over 150 years. Surgery. 2008 Oct; 144(4): 695-701.
• Spanheimer PM, Graham MM, Sugg SL, Scott-Conner CEH, Weigel RJ. Measurement of uterine radiation exposure from lymphoscintigraphy indicates safety of sentinel lymph node biopsy during pregnancy. Annals of Surgical Oncology. 2009. 16:1143-7.
• Calva D, O’Dorisio TM, O’Dorisio SM, Lal G, Sugg S, Weigel RJ, Howe JR. When is prophylactic thyroidectomy indicated for patients with the RET codon 609 mutation? Ann Surg Oncol. 2009 Aug;16(8):2237-44
• Adamovic T, McAllister D, Guryev V, Wang X, Wendt Andrae J, Cuppen E, Jacob HJ, Sugg SL. Identification of microalterations affecting inherently unstable genomic regions in chemically induced rat mammary carcinomas as revealed by long oligonucleotide array-based Comparative Genomic Hybridization. Cancer Research. 2009 Jun 15; 69(12): 5159-67
• Johnson MR, Guidroz JA, Smith BJ, Graham MM, Scott-Conner CEH, Sugg SL, Weigel RJ. A single institutional experience of factors affecting successful identification of sentinel lymph node in breast cancer patients. Surgery. 2009 Oct;146(4):671-6; discussion 676-7.
• Lal G, Nowell AG, Liao J, Sugg SL, Weigel RJ, Howe JR. Determinants of survival in patients with calciphylaxis – a multivariate analysis. Surgery. 2009 Dec; 146(6):1028-34.
• Fang SH, Guidroz JA, O’Malley Y, Lal G, Sugg SL, Howe JR, Jensen CS, Weigel RJ. Expansion of a cell population expressing stem cell markers in parathyroid glands from patients with hyperparathyroidism. Annals of Surgery 2010 Jan; 251(1):107-13.
• Lal G, Fairchild T, How JR, Weigel RJ, Sugg SL, Menda Y. PET-CT Scans in Recurrent or Persistent Differentiated Thyroid Cancer – Is there added utility beyond conventional imaging? Surgery 2010 Dec; accepted for publication.